Salivary gland malignant tumor (SGMT) is a malignant disease requiring multidisciplinary approach. The rare incidence and the consequent lack of robust evidence-based medicine has called for a comprehensive update to draw recommendations for clinical practice. This paper is a summary of the XXX Head and Neck Unit guidelines regarding the management of SGMT. Recommendations include the indications for exclusive and adjuvant therapy, as well as metastatic management, for both major and minor SGMT.
Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations / De Felice, Francesca; de Vincentiis, Marco; Valentini, Valentino; Musio, Daniela; Mezi, Silvia; Lo Mele, Luigi; Della Monaca, Marco; D'Aguanno, Vittorio; Terenzi, Valentina; Di Brino, Martina; Brauner, Edoardo; Bulzonetti, Nadia; Tenore, Gianluca; Pomati, Giulia; Cassoni, Andrea; Tombolini, Mario; Battisti, Andrea; Greco, Antonio; Pompa, Giorgio; Minni, Antonio; Romeo, Umberto; Cortesi, Enrico; Polimeni, Antonella; Tombolini, Vincenzo. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - 120:(2017), pp. 93-97. [10.1016/j.critrevonc.2017.10.010]
Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations
De Felice, Francesca
Primo
;de Vincentiis, MarcoSecondo
;Valentini, Valentino;Mezi, Silvia;Lo Mele, Luigi;Della Monaca, Marco;D'Aguanno, Vittorio;Terenzi, Valentina;Di Brino, Martina;Brauner, Edoardo;Tenore, Gianluca;Pomati, Giulia;Cassoni, Andrea;Tombolini, Mario;Battisti, Andrea;Greco, Antonio;Pompa, Giorgio;Minni, Antonio;Romeo, Umberto;Cortesi, Enrico;Polimeni, AntonellaPenultimo
;Tombolini, VincenzoUltimo
2017
Abstract
Salivary gland malignant tumor (SGMT) is a malignant disease requiring multidisciplinary approach. The rare incidence and the consequent lack of robust evidence-based medicine has called for a comprehensive update to draw recommendations for clinical practice. This paper is a summary of the XXX Head and Neck Unit guidelines regarding the management of SGMT. Recommendations include the indications for exclusive and adjuvant therapy, as well as metastatic management, for both major and minor SGMT.| File | Dimensione | Formato | |
|---|---|---|---|
|
De-Felice_Management_2017.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
162.94 kB
Formato
Adobe PDF
|
162.94 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
